IL-22 Mediates Goblet Cell Hyperplasia and Worm Expulsion in Intestinal Helminth Infection

Type 2 immune responses are essential in protection against intestinal helminth infections. In this study we show that IL-22, a cytokine important in defence against bacterial infections in the intestinal tract, is also a critical mediator of anti-helminth immunity. After infection with Nippostrongylus brasiliensis, a rodent hookworm, IL-22-deficient mice showed impaired worm expulsion despite normal levels of type 2 cytokine production. The impaired worm expulsion correlated with reduced goblet cell hyperplasia and reduced expression of goblet cell markers. We further confirmed our findings in a second nematode model, the murine whipworm Trichuris muris. T.muris infected IL-22-deficient mice had a similar phenotype to that seen in N.brasiliensis infection, with impaired worm expulsion and reduced goblet cell hyperplasia. Ex vivo and in vitro analysis demonstrated that IL-22 is able to directly induce the expression of several goblet cell markers, including mucins. Taken together, our findings reveal that IL-22 plays an important role in goblet cell activation, and thus, a key role in anti-helminth immunity.

[1]  F. Powrie,et al.  Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model , 2013, The Journal of experimental medicine.

[2]  R. Grencis,et al.  A new role for mucins in immunity: insights from gastrointestinal nematode infection. , 2013, The international journal of biochemistry & cell biology.

[3]  R. D. Hatton,et al.  Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. , 2012, Immunity.

[4]  Francis J. Huber,et al.  IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine , 2012, Nature.

[5]  F. Bushman,et al.  Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria , 2012, Science.

[6]  R. Speare,et al.  Characterising the Mucosal and Systemic Immune Responses to Experimental Human Hookworm Infection , 2012, PLoS pathogens.

[7]  R. Maizels,et al.  Diversity and dialogue in immunity to helminths , 2011, Nature Reviews Immunology.

[8]  T. Wynn,et al.  Muc5ac: a critical component mediating the rejection of enteric nematodes , 2011, The Journal of experimental medicine.

[9]  D. Artis,et al.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 , 2011, Nature Immunology.

[10]  Philip Sutton,et al.  Mucin dynamics and enteric pathogens , 2011, Nature Reviews Microbiology.

[11]  D. Artis,et al.  CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. , 2011, Immunity.

[12]  M. J. Broadhurst,et al.  IL-22+ CD4+ T Cells Are Associated with Therapeutic Trichuris trichiura Infection in an Ulcerative Colitis Patient , 2010, Science Translational Medicine.

[13]  Y. S. Kim,et al.  Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress , 2010, Current gastroenterology reports.

[14]  W. Khan,et al.  Mucin Gene Deficiency in Mice Impairs Host Resistance to an Enteric Parasitic Infection , 2010, Gastroenterology.

[15]  A. Sher,et al.  Redundant and Pathogenic Roles for IL-22 in Mycobacterial, Protozoan, and Helminth Infections , 2010, The Journal of Immunology.

[16]  M. Neurath,et al.  Activation of epithelial STAT3 regulates intestinal homeostasis , 2010, Cell cycle.

[17]  F. Finkelman,et al.  Intestinal epithelial cell secretion of RELM-β protects against gastrointestinal worm infection , 2009, The Journal of experimental medicine.

[18]  M. Neurath,et al.  STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing , 2009, The Journal of experimental medicine.

[19]  A. Murphy,et al.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. , 2008, Immunity.

[20]  Shinichiro Sawa,et al.  Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. , 2008, Immunity.

[21]  M. McGuckin,et al.  Mucin Dynamics in Intestinal Bacterial Infection , 2008, PloS one.

[22]  R. Grencis,et al.  The intestinal epithelium: sensors to effectors in nematode infection , 2008, Mucosal Immunology.

[23]  F. Brombacher,et al.  IL-4/IL-13 independent goblet cell hyperplasia in experimental helminth infections , 2008, BMC Immunology.

[24]  S. Sa,et al.  Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens , 2008, Nature Medicine.

[25]  R. Xavier,et al.  IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. , 2008, The Journal of clinical investigation.

[26]  B. Becher,et al.  IL-22 Is Expressed by Th17 Cells in an IL-23-Dependent Fashion, but Not Required for the Development of Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.

[27]  A. Murphy,et al.  Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. , 2007, Immunity.

[28]  K. Herrmann,et al.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[29]  A. Takayanagi,et al.  Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. , 2005, Gastroenterology.

[30]  M. Lazar,et al.  RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Asadullah,et al.  IL-22 increases the innate immunity of tissues. , 2004, Immunity.

[32]  R. de Waal Malefyt,et al.  Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. , 2004, International immunopharmacology.

[33]  R. Sun,et al.  Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation , 2004, Hepatology.

[34]  J. Urban,et al.  Animal model of Nippostrongylus brasiliensis and Heligmosomoides polygyrus. , 2003, Current protocols in immunology.

[35]  Philip Smith,et al.  IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. , 2002, Immunity.

[36]  S. Akira,et al.  Interleukin (Il)-18 Promotes the Development of Chronic Gastrointestinal Helminth Infection by Downregulating IL-13 , 2001, The Journal of experimental medicine.

[37]  C. Lawrence,et al.  Coordinated Muc2 and Muc3 Mucin Gene Expression in Trichinella spiralis Infection in Wild-Type and Cytokine-Deficient Mice , 2001, Digestive Diseases and Sciences.

[38]  W. Khan,et al.  Stat6 dependent goblet cell hyperplasia during intestinal nematode infection , 2001, Parasite immunology.

[39]  J. Renauld,et al.  Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Gebert,et al.  Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180 , 2000, Inflammation Research.

[41]  K. Dabbagh,et al.  IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. , 1999, Journal of immunology.

[42]  T. Komiya,et al.  Cloning and identification of the gene gob-5, which is expressed in intestinal goblet cells in mice. , 1999, Biochemical and biophysical research communications.

[43]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[44]  G. McKenzie,et al.  A distinct role for interleukin-13 in Th2-cell-mediated immune responses , 1998, Current Biology.

[45]  A. Jarry,et al.  Direct secretory effect of interleukin-1 via type I receptors in human colonic mucous epithelial cells (HT29-C1.16E). , 1996, Gut.